文献速递中医内科中药与中成药合理使用中医康复

中药外治法治疗化疗所致周围神经病变的系统评价与Meta分析

External Treatment With Chinese Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis.
PubMed 文献 · Front Pharmacol · 2022-02-18

本研究系统检索9个数据库至2021年7月,纳入33项RCT共2356例患者,评价中药外治法治疗化疗所致周围神经病变(CIPN)的疗效。Meta分析显示,中药外治组在周围神经毒性发生率、总有效率、KPS评分、中医证候评分与疗效、疼痛NRS评分及疼痛缓解率方面均显著优于对照组(p<0.01),腓总神经与正中神经传导速度亦改善(p<0.05)。

要点

  • 中药外治可显著改善CIPN患者周围神经毒性发生率与总有效率(p<0.01)。
  • 中药外治可改善KPS评分、中医证候评分与疗效、疼痛NRS评分及疼痛缓解率(p<0.01)。
  • 中药外治可改善腓总神经与正中神经传导速度(p<0.05)。

核心结论

  • 中药外治法治疗CIPN可显著改善患者临床症状与生活质量,为有效方法。

研究设计与样本

  • 系统评价与Meta分析,检索9个电子数据库自建库至2021年7月的RCT。
  • 最终纳入33项临床研究,共2356例患者,治疗组1208例、对照组1148例。
  • 使用RevMan5.3软件进行Meta分析。
  • 临床试验注册号ChiCTR1900024617。

主要发现

  • 治疗组周围神经毒性发生率、总有效率、KPS评分、中医证候评分与疗效、疼痛NRS评分及疼痛缓解率均较对照组显著改善(p<0.01)。
  • 治疗组腓总神经与正中神经传导速度较对照组改善(p<0.05)。
  • 周围神经毒性发生率与总有效率的漏斗图左右对称,发表偏倚较低。

关键数值与推荐

  • 纳入33项RCT,治疗组1208例、对照组1148例,共2356例。
  • 周围神经毒性发生率、总有效率、KPS评分、中医证候评分与疗效、疼痛NRS评分及疼痛缓解率组间差异p<0.01。
  • 腓总神经与正中神经传导速度组间差异p<0.05。

临床怎么用

  • 对CIPN患者可考虑在规范治疗基础上联合中药外治法以改善神经毒性症状与生活质量。
  • 临床决策需结合具体外治方药与患者个体情况,原文未给出统一标准处方。

局限性

  • 原文指出临床缺乏统一的中药标准处方与客观结局指标,类似研究疗效存在差异。
  • 检索截止至2021年7月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse reaction of chemotherapy. Many studies have confirmed that traditional Chinese medicine (TCM) has unique advantages for treating CIPN. However, there is no standard TCM prescription in clinical practice or objective outcome index, and similar efficacy varies. Therefore, in this study, a systematic review of randomized controlled trials (RCTs) was performed to evaluate the clinical efficacy of external treatment with Chinese herbal medicine (CHM) for CIPN. This analysis provides evidence-based medical support for the use of CHM for external treatment of CIPN. Methods: Relevant RCTs assessing CHM external treatment of CIPN were searched in nine electronic databases, including the China National Knowledge Infrastructure Database, China Biology Medicine Disc, China Science and Technology Journal Database, Wanfang Database, PubMed, Cochrane Library, MEDLINE, Web of Science, and OVID, from inception to July 2021. A meta-analysis was performed on these studies using RevMan5.3 software. Results: Based on the inclusion and exclusion criteria, 33 clinical studies were included, while 1,354 studies were screened out. There were 2,356 patients in total, including 1,208 in the treatment group and 1,148 in the control group. In the treatment group, peripheral neurotoxicity rate, total effect rate, KPS score, TCM syndrome score and efficacy, pain NRS score, and pain relief rate were significantly improved compared with those of the control group (p < 0.01). Furthermore, the peroneal and median nerve conduction velocities were also improved compared with those in the control group (p < 0.05). By creating a funnel plot for the incidence of peripheral neurotoxicity and the total effect rate, we showed that the left and right sides were symmetrical, and that the publication bias was low. Conclusion: CHM external treatment was found to be an effective method for treating CIPN as it significantly improved clinical symptoms and quality of life in patients with CIPN. Clinical Trial Registration: identifier ChiCTR1900024617.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li QY, Cai FH, Lu Y, et al. External Treatment With Chinese Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022. PMID: 35250555. doi:10.3389/fphar.2022.764473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。